Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Donkey Plasma (Sodium Citrate Anticoagulated): Lab Use Guide

Donkey Plasma (Sodium Citrate Anticoagulated) is a carefully collected and processed equine-family plasma reagent anticoagulated with sodium citrate, valued in research for its unique immunological profile, compatibility with coagulation studies, and utility as a matrix control or blocking reagent in diverse bioassay workflows.

Anticoagulant
Sodium citrate (typically 3.2% or 3.8% w/v)
Species Source
Donkey (Equus asinus)
Primary Mechanism
Calcium chelation by citrate ions prevents coagulation cascade activation
Recommended Storage
-20°C (long-term); 2–8°C (short-term, up to 1 week); avoid repeated freeze-thaw cycles
Key Applications
Coagulation assays, ELISA matrix matching, immunological blocking, antibody cross-reactivity studies

Product Overview and Composition

Donkey Plasma (Sodium Citrate Anticoagulated) (D777420) is derived from whole blood collected from healthy donor donkeys (Equus asinus) and processed under controlled conditions to yield cell-free plasma. Blood is drawn directly into sodium citrate solution, which acts as an anticoagulant by chelating free calcium ions (Ca²⁺) essential to the coagulation cascade. By removing ionized calcium from the sample, sodium citrate halts thrombin generation and fibrin polymerization, preserving the plasma in a liquid, non-clotted state that retains native coagulation factors and plasma proteins.

The resulting product is a straw-to-pale-yellow liquid matrix containing physiological concentrations of coagulation factors (I, II, V, VII, VIII, IX, X, XI, XII), von Willebrand factor, immunoglobulins, albumin, complement proteins, and other plasma constituents characteristic of the equine family. Donkey plasma is distinct from horse plasma in its immunoglobulin repertoire and glycoprotein composition, making it particularly useful in applications where cross-reactivity with equine-specific antibodies must be evaluated or avoided.

Handling, Reconstitution, and Storage Protocol

Proper handling of Donkey Plasma (Sodium Citrate Anticoagulated) is critical for maintaining the integrity of labile coagulation factors and preserving immunological activity. Follow the guidelines below:

  • Receipt and inspection: Upon receipt, confirm the product arrived on dry ice or cold pack (2–8°C). Inspect for unusual turbidity, hemolysis (red discoloration), or lipemia (milky appearance), all of which may indicate compromised sample quality. Flag any anomalies before use.
  • Aliquoting: To minimize freeze-thaw degradation, aliquot the plasma into single-use volumes immediately upon first thaw. Use low-protein-binding polypropylene tubes and label with date and lot number.
  • Thawing: Thaw aliquots at 37°C in a water bath with gentle agitation for no more than 15 minutes, or overnight at 2–8°C. Mix gently by inversion; do not vortex, as shear forces can activate platelets and denature proteins.
  • Storage: Store long-term at -20°C or below. Short-term storage (up to 7 days) is acceptable at 2–8°C. Avoid repeated freeze-thaw cycles, which degrade Factor VIII, Factor V, and von Willebrand factor preferentially. Each additional freeze-thaw cycle can result in measurable loss of labile factor activity.
  • Working temperature: Keep thawed plasma on wet ice during experiments. Complete all assays within 4 hours of thawing when coagulation factor integrity is critical.

All work with animal-derived biological fluids should be conducted under appropriate biosafety conditions (BSL-2 practices recommended). Wear personal protective equipment including gloves, lab coat, and eye protection. Consult your institutional biosafety officer for site-specific requirements.

Research Applications

Donkey Plasma (Sodium Citrate Anticoagulated) supports a broad range of research and diagnostic development applications:

  • Coagulation research: Sodium citrate anticoagulation preserves the full complement of coagulation factors in reversible chelation. Recalcification with CaCl₂ restores clotting function, enabling prothrombin time (PT), activated partial thromboplastin time (aPTT), and thrombin generation assays. Donkey plasma serves as a useful non-human comparator matrix for studying species differences in coagulation kinetics.
  • ELISA and immunoassay matrix matching: When developing or validating immunoassays intended to measure analytes in donkey-derived samples, using authentic Donkey Plasma (Sodium Citrate Anticoagulated) as the diluent or calibrator matrix minimizes matrix effects and improves assay accuracy.
  • Blocking and background reduction: Donkey plasma or its derived normal donkey serum is widely used to block non-specific antibody binding in immunohistochemistry (IHC) and immunofluorescence (IF) protocols, particularly when donkey-raised secondary antibodies are employed. Using plasma from the same species as the secondary antibody host prevents non-specific background staining.
  • Antibody cross-reactivity and specificity testing: Donkey plasma is used as a negative control or absorption reagent to assess whether antibodies raised against other species show unwanted cross-reactivity with donkey proteins, important in multi-species immunoassay panel development.
  • Pharmacokinetic and toxicokinetic studies: Researchers studying drug metabolism, protein binding, or pharmacokinetics in donkey models use this plasma as a biological matrix for method development and validation of bioanalytical assays.

Quality Considerations and Experimental Tips

To obtain reproducible results with Donkey Plasma (Sodium Citrate Anticoagulated), consider the following quality and experimental factors:

  • Lot-to-lot variability: As with all biological materials, inter-lot variation in protein concentrations, immunoglobulin levels, and factor activities is expected. For longitudinal studies or multi-site assays, reserve sufficient material from a single lot to cover the entire study. Confirm lot acceptance with an in-house qualification assay before committing to large-scale use.
  • Hemolysis and lipemia: Hemolyzed plasma releases intracellular contents that can interfere with spectrophotometric, fluorometric, and coagulation assays. Lipemic plasma can scatter light and cause turbidity artifacts. Reject visually compromised material for sensitive assays.
  • Citrate concentration and recalcification: For coagulation assays requiring recalcification, the ratio of blood to citrate at collection (typically 9:1 v/v) affects the residual citrate concentration and the amount of CaCl₂ required for activation. Confirm the citrate concentration with the product specification sheet and optimize CaCl₂ addition accordingly.
  • Protein adsorption: Plasma proteins adsorb to glass surfaces. Use siliconized or polypropylene tubes and pipette tips for all handling steps to minimize protein loss and prevent activation of the contact pathway of coagulation.
  • Sterility: Although the product is processed under aseptic conditions, it is not guaranteed sterile unless specifically stated. Add sodium azide (0.02% w/v) or filter-sterilize (0.2 µm) if microbial contamination is a concern for extended use, keeping in mind that azide inhibits peroxidase-based detection systems.

Frequently asked questions

Why is sodium citrate used as the anticoagulant instead of EDTA or heparin?

Sodium citrate is the preferred anticoagulant for coagulation studies because it reversibly chelates calcium ions, allowing coagulation to be restored by adding exogenous CaCl₂. EDTA also chelates calcium but causes irreversible conformational changes to coagulation factor proteins, making recalcification unreliable. Heparin activates antithrombin and directly inhibits multiple coagulation factors, which interferes with many factor-specific and chromogenic coagulation assays. Sodium citrate plasma is therefore the clinical and research standard for PT, aPTT, and thrombin generation testing.

How many freeze-thaw cycles can Donkey Plasma (Sodium Citrate Anticoagulated) tolerate before factor activity is significantly compromised?

Labile coagulation factors, particularly Factor VIII, Factor V, and von Willebrand factor, begin to show measurable activity loss after even a single freeze-thaw cycle. For applications requiring intact coagulation factor activity, it is best practice to aliquot plasma into single-use volumes before freezing and to limit samples to no more than one freeze-thaw cycle. For applications such as ELISA matrix matching or non-specific blocking where factor integrity is not critical, a small number of additional freeze-thaw cycles may be acceptable, but should be validated experimentally.

Can donkey plasma be used as a blocking reagent in immunofluorescence protocols using donkey secondary antibodies?

Yes. Donkey plasma or normal donkey serum is the recommended blocking reagent when donkey-raised secondary antibodies are used in immunofluorescence or immunohistochemistry. The serum proteins saturate non-specific binding sites on the tissue or membrane, and because they originate from the same species as the secondary antibody host, they do not introduce additional cross-reactive signals. It is important to use plasma or serum from the same species as the secondary antibody and not from the same species as the primary antibody target, to avoid blocking the signal of interest.

What is the difference between donkey plasma and donkey serum, and which should I choose?

Plasma is obtained by centrifuging anticoagulated whole blood and retains all coagulation factors, including fibrinogen and other clotting proteins. Serum is obtained after blood has been allowed to clot and the clot removed, so it lacks fibrinogen and labile coagulation factors but retains antibodies and most other plasma proteins. Choose plasma when you need intact coagulation factors or wish to preserve the native protein composition of the sample. Choose serum for applications such as general immunological blocking, antibody detection, or complement studies where the absence of fibrinogen is advantageous and clotting activity is not needed.

References

  1. Dacie JV, Lewis SM. Practical Haematology. 11th ed. Churchill Livingstone; 2011. Chapter on anticoagulants and blood collection for coagulation testing.
  2. Lippi G, Favaloro EJ, Franchini M, Guidi GC. Milestones and perspectives in coagulation and hemostasis. Semin Thromb Hemost. 2009;35(1):9-22.
  3. Lindblom RPF, et al. Normal donkey serum as a blocking agent in immunofluorescence applications. Laboratory Protocols in Immunohistochemistry. Generic textbook reference.
  4. Clinical and Laboratory Standards Institute (CLSI). Collection, Transport, and Processing of Blood Specimens for Testing Plasma-Based Coagulation Assays and Molecular Hemostasis Assays; Approved Guideline. 5th ed. CLSI document H21-A5.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Categories: Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Cite this article

Aladdin Scientific. "Donkey Plasma (Sodium Citrate Anticoagulated): Lab Use Guide" Aladdin Knowledge Base, updated 20 nov 2026. https://www.aladdinsci.com/eu_es/faqs/donkey-plasma-sodium-citrate-anticoagulated-lab-guide-en.html
Was this article helpful? Yes No 6 out of 13 found this helpful

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.